人类白细胞抗原-A2阳性乳腺癌患者中ErbB-2原癌基因过表达频率较低。 - Suppr | 超能文献

Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients.

作者信息

Nisticò P, Mottolese M, Mammi C, Benevolo M, Del Bello D, Rubiu O, Gentile F P, Botti C, Venturo I, Natali P G

机构信息

Laboratorio di Immunologia, CRS Istituto Tumori Regina Elena, Italy.

出版信息

J Natl Cancer Inst. 1997 Feb 19;89(4):319-21. doi: 10.1093/jnci/89.4.319.

DOI:10.1093/jnci/89.4.319

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients.人类白细胞抗原-A2阳性乳腺癌患者中ErbB-2原癌基因过表达频率较低。

J Natl Cancer Inst. 1997 Feb 19;89(4):319-21. doi: 10.1093/jnci/89.4.319.

2

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients.宿主免疫监视有助于控制HLA - A2型乳腺癌患者中erbB - 2的过表达。

Int J Cancer. 1999 Dec 22;84(6):598-603. doi: 10.1002/(sici)1097-0215(19991222)84:6<598::aid-ijc10>3.0.co;2-7.

3

mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.人乳腺癌细胞MCF-7中I型生长因子受体的mRNA表达：雌二醇和他莫昔芬的调控作用

Anticancer Res. 2003 Mar-Apr;23(2B):1455-60.

4

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.乳腺癌中p53和c-erbB-2蛋白表达。一项免疫组织化学研究，包括与人类乳腺癌受体状态、增殖标志物及临床分期的相关性。

Am J Clin Pathol. 1992 Oct;98(4):408-18. doi: 10.1093/ajcp/98.4.408.

5

Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.鉴定癌胚抗原相关细胞粘附分子（CGA）为乳腺癌中一种新的雌激素受体反应性基因：预测内分泌治疗反应的杰出候选标志物。

Cancer Res. 2001 Feb 15;61(4):1652-8.

6

Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌：大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。

Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.

7

The sensitivity and specificity of estrogen receptor, progesterone receptor and HER-2 staining in core biopsies of invasive breast carcinomas.浸润性乳腺癌粗针活检中雌激素受体、孕激素受体及HER-2染色的敏感性和特异性。

Breast J. 2007 Jul-Aug;13(4):436-7. doi: 10.1111/j.1524-4741.2007.00461.x.

8

Role of steroid hormone and growth factor receptors and proto-oncogenes in the behavior of human mammary epithelial cancer cells in vitro.

Pathobiology. 1997;65(2):75-82. doi: 10.1159/000164107.

9

Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer.

Biomarkers. 2010 Mar;15(2):191-3. doi: 10.3109/13547500903312173.

10

[Relationship of C-erbB-2 oncogene overexpression to estrogen progesterone receptors in brease cancer and its prognostic significance].[C-erbB-2癌基因过表达与乳腺癌雌激素、孕激素受体的关系及其预后意义]

Hua Xi Yi Ke Da Xue Xue Bao. 1997 Jun;28(2):214-7.

引用本文的文献

1

Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.了解ErbB激活事件和信号转导对抗原加工和呈递的影响：以MHC表达为模型

Front Pharmacol. 2016 Sep 26;7:327. doi: 10.3389/fphar.2016.00327. eCollection 2016.

2

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.在体外黑色素瘤模型中，HLA和内源性抗原表达的自然变异调节CTL识别。

Int J Cancer. 1999 Mar 1;80(5):781-90. doi: 10.1002/(sici)1097-0215(19990301)80:5<781::aid-ijc24>3.0.co;2-a.